A clinical guide to viral haemorrhagic fevers: Ebola, Marburg and Lassa

@article{Jeffs2006ACG,
  title={A clinical guide to viral haemorrhagic fevers: Ebola, Marburg and Lassa},
  author={Benjamin Jeffs},
  journal={Tropical Doctor},
  year={2006},
  volume={36},
  pages={1 - 4}
}
  • B. Jeffs
  • Published 1 January 2006
  • Medicine
  • Tropical Doctor
The viral haemorrhagic fevers are a group of diseases that share many clinical features. Ebola, Marburg and Lassa are diseases that cause a relatively small number of deaths globally, but pose special risks to medical staff due to the ease of transmission, and can have a profound impact to the communities they affect. This article gives a brief overview of diseases caused by the Ebola, Marburg and Lassa viruses. It gives some practical advice to the clinician on the diagnosis and management of… 
Clinical aspects of Marburg hemorrhagic fever.
TLDR
The clinical aspects of MHF are reviewed, the pathogenesis and possible options for diagnosis, treatment and prevention are discussed and the potential vaccines and therapeutics are discussed.
A Review on: Ebola Virus Disease (EVD)
TLDR
Ebola virus is a fatal illness in humans and non primates and no specific treatment foe EVD is available but a number of researches are going on.
Ebola virus disease: a review on epidemiology, symptoms, treatment and pathogenesis.
TLDR
This review aims to provide an overview of EVD for clinicians, with the emphasis on pathogenesis, clinical manifestations, and treatment options.
Ebola virus disease: societal challenges and new treatments
TLDR
Lack of public health infrastructure, delays in virus detection and late implementation of control interventions contributed to widespread transmission of EVD in a region inexperienced in dealing with the disease.
Ebola Hemorrhagic Fever
TLDR
Understanding the epidemiology, clinical presentation, prompt diagnosis, suitable treatment and isolation are the main factors for prevention of death and transmission of virus to other people.
Review on the Epidemiology and Public Health Importance of Marburg Hemorrhagic Fever in Africa
TLDR
The clinical aspects of MHF are reviewed, the pathogenesis and possible options for diagnosis, treatment and prevention are discussed and a range of blood, immunological and drug therapies are under development.
Filoviruses: Ebola, Marburg and Disease
TLDR
Public interest in the current West African EBOV outbreak has accelerated efforts to see several of the more advanced therapeutic and vaccination approaches licenced, and basic public health measures are very effective at controlling outbreaks, when consistently and rigorously implemented.
Viral Hemorrhagic Fevers: a Comparative Appraisal
TLDR
At present, the best-understood form of VHF is the fulminant illness caused by Ebola Zaire virus, which displays all the classic features of the HF syndrome.
THREAT OF EBOLA VIRUS DISEASE FOR PAKISTAN
TLDR
The Federal Ministry of Health has issued an advisory to take precautionary measures against Ebola, warning that it may affect Pakistan due to frequent movement of persons to the African countries and this risk of import of virus needs immediate precautionary Measures.
Infection Control During Filoviral Hemorrhagic Fever Outbreaks
TLDR
A review of the literature on infection control during filoviral hemorrhagic fever outbreaks focusing on outbreaks in a developing setting and lessons learned from previous outbreaks is provided.
...
...

References

SHOWING 1-10 OF 23 REFERENCES
Pathogenesis of filoviral haemorrhagic fevers.
Lassa fever: epidemiology, clinical features, and social consequences
TLDR
This document was created through collaboration with experts in infectious disease, community development, clinical management of viral haemorrhagic diseases, and qualitative research through a literature review using Ovid and PubMed, case analysis and surveys undertaken in the field, and relevant websites.
Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients.
TLDR
During the 1995 outbreak of Ebola hemorrhagic fever in the Democratic Republic of the Congo, a series of 103 cases had clinical symptoms and signs accurately recorded by medical workers, mainly in the setting of the urban hospital in Kikwit.
Firsthand clinical observations of hemorrhagic manifestations in Ebola hemorrhagic fever in Zaire.
  • P. Sureau
  • Medicine
    Reviews of infectious diseases
  • 1989
TLDR
The hemorrhagic manifestations were less severe in the cases that occurred by the end of the outbreak than in the first reported cases, and less frequent and less severe, or even absent, in the nonfatal cases (convalescents, serologically confirmed).
Clinical features of Lassa fever in Liberia.
  • J. Frame
  • Medicine
    Reviews of infectious diseases
  • 1989
TLDR
A great variation in mortality and incidence of abnormal bleeding is recorded in reported series of LF; it appears that hemorrhage is a marker for cases with a high mortality.
Ebola hemorrhagic fever and pregnancy.
TLDR
The mortality among pregnant women with Ebola hemorrhagic fever was slightly but not significantly higher than the overall mortality observed during the Ebola epidemic in Kikwit (77%; 245/316 infected persons).
A prospective study of the epidemiology and ecology of Lassa fever.
TLDR
It is estimated that the ratio of fatalities to infection to be 1%-2%, a rate lower than estimates based on hospitalized cases, and eightfold rises in titer of antibody occurred in 1%-18% of the antibody-positive population, a result suggesting reinfection.
Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995.
In contrast with procedures in previous Ebola outbreaks, patient care during the 1995 outbreak in Kikwit, Democratic Republic of the Congo, was centralized for a large number of patients. On 4 May,
Lassa fever. Effective therapy with ribavirin.
TLDR
It is concluded that ribavirin is effective in the treatment of Lassa fever and that it should be used at any point in the illness, as well as for postexposure prophylaxis.
...
...